CSI Market
Sign In | Register

Vaccinex Inc (VCNX) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access VCNX Annual Cash Flow →
Quarterly cash flow trends provide additional context on Vaccinex Inc's liquidity and ability to support ongoing operations and capital needs.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
12 Months 		(Sep 30 2024) (Jun 30 2024) (Mar 31 2024) (Dec 31 2023)
Operating Activities
Income-18.63
Depreciation & amortization0.09
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue-0.06
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.34
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-1.29
Gain Loss On Settlement Of Warrants1.11
Income taxes0.00
Unrealized Gain (Loss) on Derivatives0.10
Increase (Decrease) in Accounts Receivable0.12
Increase (Decrease) in Accounts Payable1.91
Increase (Decrease) in Accrued Liabilities-0.14
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.27
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-16.19
Investing Activities
Capital Expenditures-0.02
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.02
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments-0.08
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock5.92
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock1.70
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net7.13
Payment Of Deferred Offering Costs-
Deferred Offering Costs In Accounts Payable And Accrued Expenses-
Proceeds From Issuance Of Convertible Debt Net Of Discount-
Redemption Of Convertible Debt-
Proceeds From Issuance Of Common Stock And Pre Funded Warrants In Private Placement Offerings2.53
Proceeds From Issuance Of Warrants In Private Placement Offerings1.11
Proceeds From Issuance Of Common Stock And Private Placement Warrants2.45
Proceeds From Issuance Of Common Stock And Pre Funded Warrants-
Proceeds From Issuance Of Liability Classified Warrants In Private Placement Offerings-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities15.78
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-16.21
Total Cash Flow-0.43
4 historic quarters locked

Sign in to unlock the full Vaccinex Inc cash flow history.

Sign In Create Free Account

About Vaccinex Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: November 14, 2024
  • Source: vcnx-20240930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000950170-24-127139

Figures are derived from filed reports and may be restated. Historical data is subject to revision.